Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases

Current Opinion in Cell Biology

Volumn 23, Issue 2, 2011, Pages 231-238

  Ong, Derrick Sek Tong ^a   Kelly, Jeffery W ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN STRUCTURE; REVIEW;

ANIMALS; ENDOPLASMIC RETICULUM; HUMANS; PROTEIN FOLDING; PROTEIN TRANSPORT; PROTEINS; PROTEOSTASIS DEFICIENCIES; STRESS, PHYSIOLOGICAL;

EID: 79954416821     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2010.11.002     Document Type: Review

References (39)

1. Balch W.E., Morimoto R.I., Dillin A., Kelly J.W. Adapting proteostasis for disease intervention. Science 2008, 319:916-919.
2. Powers E.T., Morimoto R.I., Dillin A., Kelly J.W., Balch W.E. Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 2009, 78:21-33.
3. Deuerling E., Bukau B. Chaperone-assisted folding of newly synthesized proteins in the cytosol. Crit Rev Biochem Mol Biol 2004, 39:261-277.
4. Tang Y.C., Chang H.C., Chakraborty K., Hartl F.U., Hayer-Hartl M. Essential role of the chaperonin folding compartment in vivo. EMBO J 2008, 27:1458-1468.
5. Bukau B., Weissman J., Horwich A. Molecular chaperones and protein quality control. Cell 2006, 125:443-451.
6. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007, 8:519-529.
7. Schroder M., Kaufman R.J. The mammalian unfolded protein response. Annu Rev Biochem 2005, 74:739-789.
8. Mu T.W., Fowler D.M., Kelly J.W. Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis. PLoS Biol 2008, 6:253-265.
9. Ong D.S.T., Mu T.W., Palmer A.E., Kelly J.W. Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis. Nat Chem Biol 2010, 6:424-432.
10. Westerheide S.D., Anckar J., Stevens S.M., Sistonen L., Morimoto R.I. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 2009, 323:1063-1066.
11. Rosser M.F.N., Grove D.E., Cry D.M. The use of small molecules to correct defects in CFTR folding, maturation, and channel activity. Curr Chem Biol 2009, 3:420-431.
12. Futerman A.H., van Meer G. The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol 2004, 5:554-565.
13. Sawkar A.R., D'Haeze W., Kelly J.W. Therapeutic strategies to ameliorate lysosomal storage disorders-a focus on Gaucher disease. Cell Mol Life Sci 2006, 63:1179-1192.
14. Sawkar A.R., Schmitz M., Zimmer K.P., Reczek D., Edmunds T., Balch W.E., Kelly J.W. Chemical chaperones and permissive temperatures atter the cellular locatization of Gaucher disease associated glucocerebrosidase variants. ACS Chem Biol 2006, 1:235-251.
15. Fan J.Q. A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity. Biol Chem 2008, 389:1-11.
16. Denning G.M., Anderson M.P., Amara J.F., Marshall J., Smith A.E., Welsh M.J. Processing of mutant cystic-fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 1992, 358:761-764.
17. Fan J.Q., Ishii S., Asano N., Suzuki Y. Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat Med 1999, 5:112-115.
18. Sawkar A.R., Cheng W.C., Beutler E., Wong C.H., Balch W.E., Kelly J.W. Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease. Proc Natl Acad Sci USA 2002, 99:15428-15433.
19. Dawson G., Schroeder C., Dawson P.E. Palmitoyl:protein thioesterase (PPT1) inhibitors can act as pharmacological chaperones in infantile Batten disease. Biochem Biophys Res Commun 2010, 395:66-69.
20. Hutt D.M., Herman D., Rodrigues A.P.C., Noel S., Pilewski J.M., Matteson J., Hoch B., Kellner W., Kelly J.W., Schmidt A., et al. Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol 2010, 6:25-33.
21. Mu T.W., Ong D.S.T., Wang Y.J., Balch W.E., Yates J.R., Segatori L., Kelly J.W. Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 2008, 134:769-781.
22. Wang X.D., Venable J., LaPointe P., Hutt D.M., Koulov A.V., Coppinger J., Gurkan C., Kellner W., Matteson J., Plutner H., et al. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 2006, 127:803-815.
23. Koulov A.V., LaPointe P., Lu B.W., Razvi A., Coppinger J., Dong M.Q., Matteson J., Laister R., Arrowsmith C., Yates J.R., et al. Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis. Mol Biol Cell 2010, 21:871-884.
24. Marozkina N.V., Yemen S., Borowitz M., Liu L., Plapp M., Sun F., Islam R., Erdmann-Gilmore P., Townsend R.R., Lichti C.F., et al. Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy. Proc Natl Acad Sci USA 2010, 107:11393-11398.
25. Reczek D., Schwake M., Schroder J., Hughes H., Blanz J., Jin X.Y., Brondyk W., Van Patten S., Edmunds T., Saftig P. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-Glucocerebrosidase. Cell 2007, 131:770-783.
26. Ron I., Horowitz M. Intracellular cholesterol modifies the ERAD of glucocerebrosidase in Gaucher disease patients. Mol Gen Metab 2008, 93:426-436.
27. Settembre C., Fraldi A., Jahreiss L., Spampanato C., Venturi C., Medina D., de Pablo R., Tacchetti C., Rubinsztein D.C., Ballabio A. A block of autophagy in lysosomal storage disorders. Hum Mol Genet 2008, 17:119-129.
28. Vergarajauregui S., Connelly P.S., Daniels M.P., Puertollano R. Autophagic dysfunction in mucolipidosis type IV patients. Hum Mol Genet 2008, 17:2723-2737.
29. Raben N., Hill V., Shea L., Takikita S., Baum R., Mizushima N., Ralston E., Plotz P. Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. Hum Mol Genet 2008, 17:3897-3908.
30. Chevrier M., Brakch N., Lesueur C., Genty D., Ramdani Y., Moll S., Djavaheri-Mergny M., Brasse-Lagnel C., Laquerriere A., Barbey F., et al. Autophagosome maturation is impaired in Fabry disease. Autophagy 2010, 6:589-599.
31. Bomberger J.M., Barnaby R.L., Stanton B.A. The deubiquitinating enzyme USP10 regulates the post-endocytic sorting of cystic fibrosis transmembrane conductance regulator in airway epithelial cells. J Biol Chem 2009, 284:18778-18789.
32. Park H.J., Mylvaganum M., McPherson A., Fewell S.W., Brodsky J.L., Lingwood C.A. A soluble sulfogalactosyl ceramide mimic promotes delta F508 CFTR escape from endoplasmic reticulum associated degradation. Chem Biol 2009, 16:461-470.
33. Schmidt B.Z., Watts R.J., Aridor M., Frizzell R.A. Cysteine string protein promotes proteasomal degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) by increasing its interaction with the C terminus of Hsp70-interacting protein and promoting CFTR ubiquitylation. J Biol Chem 2009, 284:4168-4178.
34. Hassink G.C., Zhao B., Sompallae R., Altun M., Gastaldello S., Zinin N.V., Masucci M.G., Lindsten K. The ER-resident ubiquitin-specific protease 19 participates in the UPR and rescues ERAD substrates. EMBO Rep 2009, 10:755-761.
35. Tcherpakov M., Delaunay A., Toth J., Kadoya T., Petroski M.D., Ronai Z.A. Regulation of endoplasmic reticulum-associated degradation by RNF5-dependent ubiquitination of JNK-associated membrane protein (JAMP). J Biol Chem 2009, 284:12099-12109.
36. Ye S.Y., Cihil K., Stolz D.B., Pilewski J.M., Stanton B.A., Swiatecka-Urban A. c-Cbl facilitates endocytosis and lysosomal degradation of cystic fibrosis transmembrane conductance regulator in human airway epithelial cells. J Biol Chem 2010, 285:27008-27018.
37. Cheng J., Cebotaru V., Cebotaru L., Guggino W.B. Syntaxin 6 and CAL mediate the degradation of the cystic fibrosis transmembrane conductance regulator. Mol Biol Cell 2010, 21:1178-1187.
38. Okiyoneda T., Barriere H., Bagdany M., Rabeh W.M., Du K., Hohfeld J., Young J.C., Lukacs G.L. Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science 2010, 329:805-810.
39. Sardiello M., Palmieri M., di Ronza A., Medina D.L., Valenza M., Gennarino V.A., Di Malta C., Donaudy F., Embrione V., Polishchuk R.S., et al. A gene network regulating lysosomal biogenesis and function. Science 2009, 325:473-477.